Literature DB >> 31493099

How can maturity-onset diabetes of the young be identified among more common diabetes subtypes?

Jana Urbanova1, Ludmila Brunerova2, Jan Broz3.   

Abstract

Maturity onset diabetes of the young (MODY) represents a diabetes type which has an enormous clinical impact. It significantly alters treatment, refines a patient's prognosis and enables early detection of diabetes in relatives. Nevertheless, when diabetes is manifested the vast majority of MODY patients are not correctly diagnosed, but mostly falsely included among patients with type 1 or type 2 diabetes, in many cases permanently. The aim of this article is to offer a simple and comprehensible guide for recognizing individuals with MODY hidden among adult patients with another type of long-term diabetes and in women with gestational diabetes.

Entities:  

Keywords:  Differential diagnosis; Gestational diabetes; MODY; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Mesh:

Year:  2019        PMID: 31493099     DOI: 10.1007/s00508-019-01543-6

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  49 in total

1.  Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development.

Authors:  E L Edghill; C Bingham; A S Slingerland; J A L Minton; C Noordam; S Ellard; A T Hattersley
Journal:  Diabet Med       Date:  2006-12       Impact factor: 4.359

2.  Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction.

Authors:  Helge Raeder; Stefan Johansson; Pål I Holm; Ingfrid S Haldorsen; Eric Mas; Véronique Sbarra; Ingrid Nermoen; Stig A Eide; Louise Grevle; Lise Bjørkhaug; Jørn V Sagen; Lage Aksnes; Oddmund Søvik; Dominique Lombardo; Anders Molven; Pål Rasmus Njølstad
Journal:  Nat Genet       Date:  2005-12-20       Impact factor: 38.330

3.  High frequency of mutations in the HNF-1alpha gene in non-obese patients with diabetes of youth in Japanese and identification of a case of digenic inheritance.

Authors:  N Tonooka; H Tomura; Y Takahashi; K Onigata; N Kikuchi; Y Horikawa; M Mori; J Takeda
Journal:  Diabetologia       Date:  2002-11-16       Impact factor: 10.122

4.  Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus.

Authors:  M T Malecki; U S Jhala; A Antonellis; L Fields; A Doria; T Orban; M Saad; J H Warram; M Montminy; A S Krolewski
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

5.  Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes.

Authors:  E R Pearson; W G Liddell; M Shepherd; R J Corrall; A T Hattersley
Journal:  Diabet Med       Date:  2000-07       Impact factor: 4.359

Review 6.  The rise and fall of insulin secretion in type 1 diabetes mellitus.

Authors:  E B Tsai; N A Sherry; J P Palmer; K C Herold
Journal:  Diabetologia       Date:  2006-01-11       Impact factor: 10.122

7.  Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations.

Authors:  Ewan R Pearson; Michael K Badman; Christopher R Lockwood; Penelope M Clark; Sian Ellard; Coralie Bingham; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

8.  Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function.

Authors:  Bernadette Neve; Martin E Fernandez-Zapico; Vered Ashkenazi-Katalan; Christian Dina; Yasmin H Hamid; Erik Joly; Emmanuel Vaillant; Yamina Benmezroua; Emmanuelle Durand; Nicolas Bakaher; Valerie Delannoy; Martine Vaxillaire; Tiffany Cook; Geesje M Dallinga-Thie; Hans Jansen; Marie-Aline Charles; Karine Clément; Pilar Galan; Serge Hercberg; Nicole Helbecque; Guillaume Charpentier; Marc Prentki; Torben Hansen; Oluf Pedersen; Raul Urrutia; Danielle Melloul; Philippe Froguel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-17       Impact factor: 11.205

9.  The genetic abnormality in the beta cell determines the response to an oral glucose load.

Authors:  A Stride; M Vaxillaire; T Tuomi; F Barbetti; P R Njølstad; T Hansen; A Costa; I Conget; O Pedersen; O Søvik; R Lorini; L Groop; P Froguel; A T Hattersley
Journal:  Diabetologia       Date:  2002-03       Impact factor: 10.122

Review 10.  Monogenic diabetes in children and young adults: Challenges for researcher, clinician and patient.

Authors:  Annabelle S Slingerland
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

View more
  2 in total

Review 1.  Update on clinical screening of maturity-onset diabetes of the young (MODY).

Authors:  Renata Peixoto-Barbosa; André F Reis; Fernando M A Giuffrida
Journal:  Diabetol Metab Syndr       Date:  2020-06-08       Impact factor: 3.320

Review 2.  Biomarkers: Tools for Discriminating MODY from Other Diabetic Subtypes.

Authors:  Parveena Firdous; Kamran Nissar; Shariq Rashid Masoodi; Bashir Ahmad Ganai
Journal:  Indian J Endocrinol Metab       Date:  2022-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.